BLASI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 34.973
NA - Nord America 22.850
AS - Asia 10.949
SA - Sud America 1.818
AF - Africa 226
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 17
Totale 70.878
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 24.702
US - Stati Uniti d'America 22.463
GB - Regno Unito 3.773
SG - Singapore 3.462
CN - Cina 3.454
HK - Hong Kong 1.613
BR - Brasile 1.452
SE - Svezia 1.262
DE - Germania 1.183
FR - Francia 815
VN - Vietnam 714
UA - Ucraina 612
RU - Federazione Russa 544
NL - Olanda 512
TR - Turchia 403
FI - Finlandia 381
KR - Corea 327
BG - Bulgaria 256
IN - India 212
ID - Indonesia 185
MX - Messico 162
AR - Argentina 160
CA - Canada 158
PL - Polonia 112
RO - Romania 112
IE - Irlanda 110
AT - Austria 93
JP - Giappone 90
ZA - Sudafrica 86
ES - Italia 82
BE - Belgio 73
BD - Bangladesh 71
CH - Svizzera 67
IR - Iran 62
IQ - Iraq 55
EC - Ecuador 53
LT - Lituania 53
CO - Colombia 40
CZ - Repubblica Ceca 38
MA - Marocco 38
AU - Australia 37
MY - Malesia 37
NO - Norvegia 31
PE - Perù 31
PT - Portogallo 31
PK - Pakistan 29
AE - Emirati Arabi Uniti 26
DK - Danimarca 25
IL - Israele 25
PY - Paraguay 25
CL - Cile 23
TH - Thailandia 22
EG - Egitto 21
UZ - Uzbekistan 20
TW - Taiwan 19
SA - Arabia Saudita 17
DZ - Algeria 16
HU - Ungheria 16
TN - Tunisia 16
VE - Venezuela 16
AL - Albania 15
PH - Filippine 14
DO - Repubblica Dominicana 13
KE - Kenya 13
RS - Serbia 13
GR - Grecia 12
PA - Panama 12
UY - Uruguay 12
EU - Europa 11
JO - Giordania 11
KG - Kirghizistan 11
AZ - Azerbaigian 9
HN - Honduras 9
NP - Nepal 9
SK - Slovacchia (Repubblica Slovacca) 9
CR - Costa Rica 8
AM - Armenia 7
HR - Croazia 7
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
CI - Costa d'Avorio 6
LB - Libano 6
LV - Lettonia 6
SN - Senegal 6
JM - Giamaica 5
PS - Palestinian Territory 5
SI - Slovenia 5
AO - Angola 4
BH - Bahrain 4
BO - Bolivia 4
EE - Estonia 4
KW - Kuwait 4
LU - Lussemburgo 4
ML - Mali 4
MT - Malta 4
SM - San Marino 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
GE - Georgia 3
GT - Guatemala 3
Totale 70.819
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.723
Southend 2.496
Singapore 2.289
Fairfield 1.913
Ashburn 1.881
Hong Kong 1.593
Chandler 1.435
Milan 1.307
Rome 1.205
Woodbridge 1.163
Hefei 1.155
Houston 1.102
Jacksonville 1.019
Dearborn 765
Wilmington 730
Ann Arbor 695
Seattle 680
Nyköping 655
Bologna 625
London 617
Cambridge 554
Beijing 539
Modena 506
Los Angeles 440
Florence 365
New York 365
Chicago 337
Torino 308
Princeton 262
Catania 250
Sofia 250
Seoul 249
Ho Chi Minh City 247
Naples 247
Turin 226
San Diego 222
Padova 215
Palermo 208
Verona 198
Moscow 193
Helsinki 186
Dallas 181
Council Bluffs 180
Eugene 176
The Dalles 170
Izmir 168
Buffalo 163
Bari 161
São Paulo 158
Munich 151
Genova 142
Bremen 139
Hanoi 132
Salt Lake City 130
Shanghai 130
Jakarta 129
Redwood City 127
Cagliari 124
Genoa 124
Napoli 115
Castelnuovo Rangone 111
Venezia 107
Parma 106
Dublin 96
Pisa 95
Mexico City 92
Trento 92
Reggio Emilia 88
Trieste 86
Reggio Nell'emilia 80
Tokyo 80
Nuremberg 76
Boardman 73
Des Moines 72
Falls Church 68
Elk Grove Village 67
Bolzano 66
Perugia 66
Warsaw 65
Messina 64
Norwalk 63
Sassari 63
Columbus 62
Carpi 61
Monza 59
Pavia 58
Bergamo 57
Frankfurt am Main 57
Tampa 56
Timisoara 56
Brooklyn 55
Johannesburg 55
Brussels 54
Stockholm 54
Phoenix 52
Piemonte 52
Redondo Beach 52
Guangzhou 51
Udine 50
Kent 48
Totale 37.980
Salva come PNG Salva come JPEG
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.201
MARKER INNOVATIVI NELLA DIAGNOSTICA DELLE MICOSI INVASIVE 7.622
RICERCA DI DNA DI Pneumocystis jirovecii NEL LIQUIDO DI LAVAGGIO BRONCOALVEOLARE MEDIANTE IL TEST IN REAL-TIME PCR MYCASSAY™ PNEUMOCYSTIS 951
Yessotoxin inhibits phagocytic activity of macrophages. 413
Ruolo della proteina pneumococcica di superficie PspC nel l’interazione in vitro di Streptococcus pneumoniae con le cellule microgliali 408
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 394
Evaluation of benzydamine effects on Candida albicans adhesion, biofilm formation and persistence onto abiotic surfaces 393
Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds 388
DIAGNOSI SIEROLOGICA, MEDIANTE MYCOARRAY, DI UN CASO DI ISTOPLASMOSI DA IMPORTAZIONE IN UN TURISTA ITALIANO DI RITORNO DAL BRASILE 383
Propolis affects Pseudomonas aeruginosa Growth, Biofilm Formation, Phenazines and eDNA Release: Potential Involvement of Polyphenols 379
A transmissible cytotoxic activity isolated from a patient with brain ischemia causes microglial cell activation and dysfunction 377
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 375
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 361
EFFETTI DELLA TOSSINA DI ORIGINE ALGALE YESSOTOSSINA (YTX) SULLA ATTIVITA’ DEL MACROFAGO 358
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 352
IL GENOTIPO HWP1 DI CANDIDA ALBICANS INFLUENZA LA SUSCETTIBILITÀ FUNGINA ALLE CELLULE MICROGLIALI, MA NON LA PRODUZIONE DI BIOFILM 348
Human herpesvirus-6 dysregulates monocyte-mediated anticryptococcal defences 344
RUOLO BIOLOGICO DI DUE RECETTORI TOLL-SIMILI, TLR2 E TLR4, NELLA RISPOSTA MACROFAGICA A CANDIDA ALBICANS 343
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization 328
La proteina di superficie PspC di pneumococco conferisce resistenza al killing in vitro di Streptococcus pneumoniae da parte di cellule microgliali in maniera indipendente dal complemento 326
NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins 325
Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment. 324
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 321
Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC) 317
Antiviral activity of Hyaluronic Acid 316
In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. 315
Differential efficacy of endodontic obturation procedures: an ex vivo study 312
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 310
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 308
Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens. 305
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 298
Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals. 297
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 296
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array 295
I MICROARRAY PROTEICI: POSSIBILI SCENARI NELLA DIAGNOSTICA DELLE MICOSI INVASIVE 289
Candida albicans biofilm can retain and release Human Herpes simplex virus type 1 in vitro 289
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 287
I MICROARRAY PROTEICI: NUOVI STRUMENTI DI INDAGINE NELLA DIAGNOSTICA DELLE INFEZIONI DA PATOGENI DEL COMPLESSO TORCH. 287
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 286
Herpes Simplex Virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals and UVA1 laser treatment 285
Evaluation of Biological Response of STRO-1/c-Kit Enriched Human Dental Pulp Stem Cells to Titanium Surfaces Treated with Two Different Cleaning Systems. 285
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 282
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 282
Role of the (Mn)superoxide dismutase of Enterococcus faecalis in the in vitro interaction with microglia 275
Contribution of different pneumococcal virulence factors to experimental meningitis in mice 274
In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. 273
Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells 272
Effects of different mouthwashes on biofilm formation by oral streptococci 268
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 265
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 264
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 264
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglial cells 263
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 262
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 261
Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2 259
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 256
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 254
S100B expression in and effects on microglia 253
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration 253
Apoptosis and inflammatory response in human astrocytes are induced by a transmissible cytotoxic agent of neurological origin 250
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 248
An in vitro and ex vivo study on two antibiotic-based endodontic irrigants: a challenge to sodium hypochlorite 247
Antibacterial Effects of MicroRepair®BIOMA-Based Toothpaste and Chewing Gum on Orthodontic Elastics Contaminated In Vitro with Saliva from Healthy Donors: A Pilot Study 246
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 245
RUOLO DELLA SUPEROSSIDO DISMUTASI DI Enterococcus faecalis SULLA REATTIVITA’ DELLA MICROGLIA IN VITRO 245
Effects of different mouthwashes on Candida albicans adhesion, susceptibility to phagocytic cells and capacity to elicit pro-inflammatory cytokine response 241
Candida albicans hyphal form enhances tumor necrosis factor mRNA levels and protein secretion in murine ANA-1 macrophages. 240
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 240
Gene expression profiling on monocytes displaying Herpes Simplex virus 1-induced dysregulation of antifungal defences. 239
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 237
Differential effector and secretory functions of microglial cell lines derived from BCG-resistant and -susceptible congenic mouse strains 235
In vitro interactions between viruses and Candida biofilm. 235
Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement 234
Differential microbial clearance and immunoresponse of Balb/c (Nramp1 susceptible) and DBA2 (Nramp1 resistant) mice intracerebrally infected with Mycobacterium bovis BCG (BCG). 234
IL MYCOARRAY: UN TEST RAPIDO PER LA DIAGNOSI SIEROLOGICA DI MICOSI ENDEMICHE 234
Nramp1 gene affects selective early steps in macrophage-mediated anti-cryptococcal defense 232
Candida metapsilosis as the least virulent member of the 'C. parapsilosis' complex 232
DETECTION OF ANTIGEN-SPECIFIC ANTIBODIES IN SERUM AND FOLLICULAR FLUIDS BY PROTEIN MICROARRAYS. 231
Beretti F., Cermelli C., Cenacchi V., Orsi C., Blasi E., Portolani M. 230
Microglial cell-mediated anti-Candida activity: temperature, ions, protein kinase C as crucial elements. 230
The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae 229
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 229
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 227
The TIGR4 strain of Streptococcus pneumoniae is phagocytosed but resists intracellular killing by microglia in experimental pneumococcal meningitis 227
Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro 225
A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: characterization of the local immune reaction by RT-PCR and histochemical analysis 224
Efficacy of a Copper-Calcium-Hydroxide Solution in Reducing Microbial Plaque on Orthodontic Clear Aligners: A Case Report 221
Evaluation of antimicrobial effect of air-polishing treatments and their influence on human dental pulp stem cells seeded on titanium disks 219
The Pneumococcal surface protein C (PspC) influences the susceptibility of Streptococcus pneumoniae to microglia 217
Iron regulates microglial cell-mediated secretory and effector functions 216
Interaction between Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium avium subspecies paratuberculosis with the enteric glia and microglial cells 216
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 214
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 214
Biomolecular events involved in the establishment of brain anticandidal resistance 210
Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain 210
COMPARAZIONE DELLA EFFICACIA ANTIBATTERICA DI TETRACLEAN, UN IRRIGANTE ENDODONTICO DI NUOVA GENERAZIONE, CON IPOCLORITO DI SODIO. 209
Routine use of a protease zymogen-based colorimetric assay for the detection of Beta-glucan and its role in clinical practice 207
Wide spectrum activity of a high molecular weight Hyaluronic Acid. 205
Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. 205
A murine macrophage cell line, immortalized by v-raf and v-myc oncogenes, exhibits normal macrophage differentiated functions 205
Totale 50.505
Salva come PNG Salva come JPEG
Categoria #
all - tutte 215.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.573 0 0 0 0 0 596 433 586 346 598 498 516
2021/20225.472 457 438 383 413 222 369 298 338 536 461 849 708
2022/20237.699 654 579 548 657 763 886 387 770 894 333 579 649
2023/20247.062 473 503 578 570 906 579 735 726 268 534 501 689
2024/202513.226 666 432 456 1.034 2.262 1.620 918 988 1.385 851 1.178 1.436
2025/202610.896 1.387 1.019 1.807 2.976 3.150 557 0 0 0 0 0 0
Totale 71.467